Neurocrine Biosciences, Inc. (NBIX) Ownership

$128.63

$1.47 (-1.13%)
Last update: 06:14 PM EST
Day's range
$127.16
Day's range
$129.45

Neurocrine Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 12.83 M $1.82 B   0.98% 12.90%
VANGUARD GROUP INC 01/29/2026 9.70 M $1.38 B   -0.06% 9.75%
DODGE & COX 02/13/2026 5.51 M $781.21 M   -0.87% 5.54%
JPMORGAN CHASE & CO 02/11/2026 5.20 M $737.57 M   9.94% 5.23%
STATE STREET CORP 02/13/2026 4.24 M $601.74 M   -2.39% 4.26%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 3.27 M $462.65 M   17.96% 3.29%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 2.24 M $317.53 M   -7.42% 2.25%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.06 M $291.34 M   1.70% 2.07%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 1.87 M $265.54 M   -34.69% 1.88%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 1.74 M $247.43 M   -3.71% 1.75%
BELLEVUE GROUP AG 02/17/2026 1.70 M $241.58 M   -3.39% 1.71%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 02/13/2026 1.40 M $197.99 M   47.24% 1.40%
LOS ANGELES CAPITAL MANAGEMENT LLC 02/11/2026 1.29 M $178.25 M   7.36% 1.30%
NORTHERN TRUST CORP 02/17/2026 1.22 M $173.20 M   31.92% 1.23%
MORGAN STANLEY 02/13/2026 1.21 M $171.53 M   -33.80% 1.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/17/2026 1.18 M $167.98 M   0.00% 1.19%
NORGES BANK 02/10/2026 1.15 M $162.66 M   100.00% 1.15%
RTW INVESTMENTS, LP 02/17/2026 1.06 M $150.63 M   0.00% 1.07%
TWO SIGMA INVESTMENTS, LP 02/17/2026 984.81 K $139.68 M   183.35% 0.99%
UBS GROUP AG 01/29/2026 983.53 K $139.49 M   169.78% 0.99%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 850.63 K $120.65 M   2.54% 0.85%
TWO SIGMA ADVISERS, LP 02/17/2026 842.59 K $119.50 M   466.36% 0.85%
ARMISTICE CAPITAL, LLC 02/17/2026 820.24 K $116.33 M   17.68% 0.82%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 776.93 K $110.30 M   12.04% 0.78%
BRAIDWELL LP 02/17/2026 751.53 K $106.59 M   -14.63% 0.76%
IEQ CAPITAL, LLC 02/13/2026 745.11 K $105.68 M   7.58% 0.75%
BANK OF NEW YORK MELLON CORP 02/10/2026 738.68 K $104.77 M   -2.98% 0.74%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 722.48 K $102.47 M   -5.59% 0.73%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 716.48 K $101.61 M   0.89% 0.72%
FIERA CAPITAL CORP 02/11/2026 637.41 K $90.40 M   32.88% 0.64%
RAYMOND JAMES FINANCIAL INC 02/18/2026 631.42 K $89.22 M   11.37% 0.63%
AMERIPRISE FINANCIAL INC 02/17/2026 585.68 K $83.07 M   -4.70% 0.59%
SWEDBANK AB 02/09/2026 584.13 K $82.85 M   6.72% 0.59%
GW&K INVESTMENT MANAGEMENT, LLC 02/11/2026 576.65 K $81.79 M   -2.98% 0.58%
ALLIANCEBERNSTEIN L.P. 02/17/2026 555.49 K $78.79 M   -10.13% 0.56%
FRANKLIN RESOURCES INC 02/11/2026 532.76 K $75.56 M   -16.10% 0.54%
BANK OF AMERICA CORP /DE/ 02/17/2026 528.10 K $74.90 M   -25.01% 0.53%
PRIMECAP MANAGEMENT CO/CA/ 02/11/2026 507.74 K $72.01 M   -0.88% 0.51%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 02/17/2026 507.17 K $39.86 M   161.50% 0.51%
FIRST TRUST ADVISORS LP 02/13/2026 486.81 K $69.04 M   34.07% 0.49%
ZURICH INSURANCE GROUP LTD/FI 02/17/2026 459.44 K $65.16 M   100.00% 0.46%
JANUS HENDERSON GROUP PLC 02/17/2026 459.18 K $65.13 M   -22.85% 0.46%
MILLENNIUM MANAGEMENT LLC 02/17/2026 442.87 K $62.81 M   -54.68% 0.45%
HOOD RIVER CAPITAL MANAGEMENT LLC 02/17/2026 389.30 K $55.21 M   -22.37% 0.39%
DEUTSCHE BANK AG\ 02/11/2026 367.94 K $52.19 M   -18.38% 0.37%
GOLDMAN SACHS GROUP INC 02/10/2026 364.53 K $51.70 M   -40.20% 0.37%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 360.71 K $51.16 M   -12.38% 0.36%
MARSHALL WACE, LLP 02/13/2026 348.84 K $49.48 M   258.56% 0.35%
INVESCO LTD. 02/19/2026 343.42 K $48.71 M   6.12% 0.35%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/15/2026 339.43 K $47.72 M   -11.25% 0.34%

Neurocrine Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 849 institutional investors and hedge funds held shares of Neurocrine Biosciences, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 12.83 M

VANGUARD GROUP INC: 9.7 M

DODGE & COX: 5.51 M

JPMORGAN CHASE & CO: 5.2 M

STATE STREET CORP: 4.24 M

AQR CAPITAL MANAGEMENT LLC: 3.27 M

99.48% of Neurocrine Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 121.99 M shares in the last 24 months. This purchase volume represents approximately $15.69 B in transactions.